Comparison of Different Treatment Schedules of Mitomycin C Intravesical Instillation in High-Risk Superficial Bladder Cancer Patients
Hong-Ray Chen, Chien-Chang Kao, Chih-Wei Tsao, Shou-Hung Tang, Meng En, Tai-Lung Cha, Guang-Huan Sun, Seng-Tang Wu · Aktuelle Urologie · 2019 · Heft 03 · S. 292-297
Bibliografische Angaben
Zusammenfassung
Abstract Objective This study was performed to compare the efficacy of intravesical mitomycin C (MMC) instillation for the prophylaxis of Ta or T1 high-risk nonmuscle invasive bladder cancer (NMIBC) using different schedules. Materials and methods This retrospective cohort study was conducted on 152 patients treated with intravesical MMC from April 2009 to September 2016. The mean follow-up time was 32.67 months. All patients underwent a complete transurethral resection of bladder tumor (TURBT) and postoperative instillation of MMC within 24 h. The patients were divided into 4 treatment groups: Group 1 was follo…
